International sales orders for 2023
Newbury Pharmaceuticals has received orders for international markets covering shipments during 2023 totalling a value of app. 6.2 MSEK.
“We are pleased to announce an update on our international sales activities. The confirmed orders represent a value of app. 6.2 MSEK with shipments divided across the entire year (2023). These orders provide a solid financial platform and support the sales growth together with the launch of new products in Scandinavia.” Says Mr. Lars Minor, CEO of Newbury.
The international sales activities are conducted by the subsidiary in Switzerland. Newbury focus on the Scandinavian markets, but international sales opportunities contribute to improved sales and profitability.
